Archived NHGRI record

2019 State Bills Louisiana 2019 HB 345

Louisiana

Status: Enacted
Database: NHGRI archive
Source database updated: February 8, 2024
Snapshot retrieved: September 1, 2026

Summary

Requires health plans to cover the cost of the genetic testing of the BRCA1 and BRCA2 genes to detect an increased risk for breast and ovarian cancer when recommended by a healthcare provider in accordance with the United States Preventive Services Task Force recommendations. Signed by the Governor June 5, 2019. Effective January 1, 2020.

Record details

Archived source metadata

Jurisdiction: Louisiana
Status: Enacted
NHGRI topic(s): Health Insurance Coverage
Record year or session: 2019
NHGRI database updated: February 8, 2024
Snapshot retrieved: September 1, 2026 at 2:32 AM UTC
Source row: 502
Stable source ID: nhgri-4ee3dca5323343f88595
Permanent URL: https://whoownsyourdna.org/source-records/nhgri/nhgri-4ee3dca5323343f88595/

Source links

Archive details

Courtesy: National Human Genome Research Institute. This archive preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.

Report a source problem

Report a transcription problem, changed legal status, or newer official source for human review. Any correction remains separate from the archived NHGRI wording.

Submit information about this archived record

Cite this archived record

NHGRI Genome Statute and Legislation Database. 2019 State Bills Louisiana 2019 HB 345. Archived by Who Owns Your DNA? Retrieved September 1, 2026. https://whoownsyourdna.org/source-records/nhgri/nhgri-4ee3dca5323343f88595/